Evaluative Study of Quality of Life in pre-menopausal women with low-risk early breast cancer (Goserelin Study)
Phase of Trial: Phase IV
Latest Information Update: 21 Jun 2016
At a glance
- Drugs Goserelin (Primary) ; Antineoplastics; Tamoxifen
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 08 Jun 2016 Status changed from active, no longer recruiting to completed.
- 19 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by Australian New Zealand Clinical Trials Registry record.
- 15 May 2009 New trial record